PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, AN EMERGING POTENTIAL TARGET TO COMBAT METABOLIC DISORDER

Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2017, Vol 10, Issue 12

Abstract

  Day-by-day metabolic disorder/syndrome (MS) falling in love with current lifestyle status of everyone especially after study age group of people. If we look carefully around us, we will see evidence is growing up of diabetic, obese, and hypertensive population regularly. In urgencies of above view extensive literature survey has been done prioritizing prevalence of metabolic disorder and peroxisome proliferator-activated receptor-gamma (PPAR-γ) as potential target protein. This review covered current status of MS emphasizing diabetes along with its management criteria. Special importance is given to PPAR-γ exploring its metabolic regulation and structural orientation for understanding ligand-protein interaction. Development of PPAR-γ agonist thiazolidinediones (TZDs) and other pharmacodynamic importance of this nuclear receptor also discussed. Being as nuclear receptor more genomics exploitation needs to be done emphasizing minimization of cardiac adverse effect. Selective PPAR modulator (SPPRM), TZDs are the master regulator of adipogenesis and angiogenesis which makes TZD more interesting topic to explore. Developmental hierarchy suggests that in a few years from now PPAR-γ won’t be in the list of double edge sword.

Authors and Affiliations

Partha Sarathi Bairy

Keywords

Related Articles

ANTIPROLIFERATIVE AND APOPTOTIC EFFECTS OF FICUS PSEUDOPALMA BLANCO (MORACEAE) AGAINST HEPATOCARCINOMA (HepG2)

Objectives.Hepatocellular carcinoma is the third most frequent cause of cancer-related death in the Philippines.  The prevalence of this disease continuously pose a great challenge to the medical and health sectors of t...

SIMULTANEOUS DETERMINATION OF DIPHENHYDRAMINE, EPHEDRINE, NOSCAPINE, AND GLYCEROL GLYCOLATE USING STABILITY-INDICATING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY: APPLICATION TO NOSCOF TABLETS

Objective: Noscof tablet is a fixed dosage combination formulation having diphenhydramine (DH), ephedrine (ED), noscapine (NP), and glycerol glycolate (GG). A sensitive, selective, accurate, precise, and stability-indica...

AN ETHNOBOTANICAL STUDY OF WILD MEDICINAL PLANTS USED BY MIGRATORY SHEPHERDS – A TRIBAL COMMUNITY OF WESTERN HIMALAYAS

Objectives: Migratory shepherds of Kinnaur, Shimla, and Sirmaur districts in Himachal Pradesh of the western Himalayas have rich traditional knowledge of medicinal plants and its uses, in this respect; an ethnobotanical...

THE ROLE OF PHARMACISTS IN EVALUATING AND INTERVENING THE PATIENTS WITH DIABETIC NEUROPATHY

Diabetic neuropathies is the presence of and/or signs of peripheral nerve dysfunctions in people with diabetes after the exclusion of other causes. The purpose of this study was to estimate the prevalence and risk factor...

SITTING VERSUS LATERAL POSITION FOR INDUCTION OF SPINAL ANESTHESIA IN ELDERLY PATIENTS – A RANDOMIZED CONTROLLED TRIAL

Objectives: To compare the effect of induction position (sitting versus lateral) for spinal anaesthesia in the elderly patient on hemodynamic, sensory block and motor block characteristics and patient satisfaction.Materi...

Download PDF file
  • EP ID EP605497
  • DOI 10.22159/ajpcr.2017.v10i12.21596
  • Views 96
  • Downloads 0

How To Cite

Partha Sarathi Bairy (2017). PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, AN EMERGING POTENTIAL TARGET TO COMBAT METABOLIC DISORDER. Asian Journal of Pharamceutical and Clinical Research, 10(12), 40-44. https://europub.co.uk/articles/-A-605497